ARCHIVES

Avastin May Trigger Two FDA Decisions: One On Approval, Another On Withdrawal

This article is from The Cancer Letter archive.

Vol. 36 No. 31 | September 3, 2010

Download PDF Visit The Full Archive

Related Articles

Mayo Clinic Study Finds Samarium May Expand Options For Osteosarcoma

February 22, 2002

Chronobiology Review Still Delayed

May 5, 1989

DCCR Advisors Okay New Programs; $300,000 Year Demonstrations In Six Communities Supported

November 17, 1978

Senate Confirms McClellan For FDA

October 25, 2002

Sen. Brown Introduces Bill on Clinical Trials Coverage

April 3, 2009

NIH to ban consulting by top officials, limit outside work by other employees.

June 25, 2004